Literature DB >> 26013250

Evaluation of Skin Fibroblasts from Amyotrophic Lateral Sclerosis Patients for the Rapid Study of Pathological Features.

Shu Yang1, Katharine Y Zhang, Ruvini Kariawasam, Monique Bax, Jennifer A Fifita, Lezanne Ooi, Justin J Yerbury, Garth A Nicholson, Ian P Blair.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterised by the progressive degeneration of brain and spinal cord motor neurons. Ubiquitin-proteasome system (UPS) dysfunction and oxidative stress have been implicated in ALS pathogenesis. However, it is unknown whether the defects in these pathways extend to non-neuronal tissues such as fibroblasts. Fibroblasts, unlike neuronal tissue, are readily available and may hold potential for short-term, rapid diagnostic and prognostic purposes. We investigated whether primary skin fibroblasts from ALS patients share, or can be manipulated to develop, functional and pathological abnormalities seen in affected neuronal cells. We inhibited UPS function and induced oxidative stress in the fibroblasts and found that ALS-related cellular changes, such as aggregate formation and ubiquitination of ALS-associated proteins (TDP-43 and ubiquilin 2), can be reproduced in these cells. Higher levels of TDP-43 ubiquitination, as evident by colocalization between TDP-43 and ubiquitin, were found in all six ALS cases compared to controls following extracellular insults. In contrast, colocalization between ubiquilin 2 and ubiquitin was not markedly different between ALS cases and control. A UPS reporter assay revealed UPS abnormalities in patient fibroblasts. Despite the presence of ALS-related cellular changes in the patient fibroblasts, no elevated toxicity was observed. This suggests that aggregate formation and colocalization of ALS-associated proteins may be insufficient alone to confer toxicity in fibroblasts used in the present study. Chronic exposure to ALS-linked stresses and the ALS-linked cellular pathologies may be necessary to breach an unknown threshold that triggers cell death.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26013250     DOI: 10.1007/s12640-015-9532-1

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  38 in total

1.  Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients.

Authors:  N Shibata; R Nagai; K Uchida; S Horiuchi; S Yamada; A Hirano; M Kawaguchi; T Yamamoto; S Sasaki; M Kobayashi
Journal:  Brain Res       Date:  2001-10-26       Impact factor: 3.252

2.  Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy.

Authors:  Cara Rothenberg; Deepa Srinivasan; Leann Mah; Susmita Kaushik; Corrine M Peterhoff; Janet Ugolino; Shengyun Fang; Ana Maria Cuervo; Ralph A Nixon; Mervyn J Monteiro
Journal:  Hum Mol Genet       Date:  2010-06-07       Impact factor: 6.150

3.  Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis.

Authors:  K Abe; L H Pan; M Watanabe; H Konno; T Kato; Y Itoyama
Journal:  Neurol Res       Date:  1997-04       Impact factor: 2.448

4.  Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis.

Authors:  Makoto Urushitani; Junko Kurisu; Kayoko Tsukita; Ryosuke Takahashi
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

5.  Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking.

Authors:  Todd J Cohen; Andrew W Hwang; Travis Unger; John Q Trojanowski; Virginia M Y Lee
Journal:  EMBO J       Date:  2011-12-23       Impact factor: 11.598

6.  UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis.

Authors:  Kelly L Williams; Sadaf T Warraich; Shu Yang; Jennifer A Solski; Ruvini Fernando; Guy A Rouleau; Garth A Nicholson; Ian P Blair
Journal:  Neurobiol Aging       Date:  2012-06-19       Impact factor: 4.673

7.  Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations.

Authors:  Mario Sabatelli; Marcella Zollino; Amelia Conte; Alessandra Del Grande; Giuseppe Marangi; Matteo Lucchini; Massimiliano Mirabella; Angela Romano; Roberto Piacentini; Giulia Bisogni; Serena Lattante; Marco Luigetti; Paolo Maria Rossini; Alice Moncada
Journal:  Neurobiol Aging       Date:  2015-02-17       Impact factor: 4.673

Review 8.  Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.

Authors:  P H Tu; M E Gurney; J P Julien; V M Lee; J Q Trojanowski
Journal:  Lab Invest       Date:  1997-04       Impact factor: 5.662

9.  Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system.

Authors:  Xiaoju Wang; Huadong Fan; Zheng Ying; Bin Li; Hongfeng Wang; Guanghui Wang
Journal:  Neurosci Lett       Date:  2009-11-26       Impact factor: 3.046

10.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.

Authors:  Han-Xiang Deng; Wenjie Chen; Seong-Tshool Hong; Kym M Boycott; George H Gorrie; Nailah Siddique; Yi Yang; Faisal Fecto; Yong Shi; Hong Zhai; Hujun Jiang; Makito Hirano; Evadnie Rampersaud; Gerard H Jansen; Sandra Donkervoort; Eileen H Bigio; Benjamin R Brooks; Kaouther Ajroud; Robert L Sufit; Jonathan L Haines; Enrico Mugnaini; Margaret A Pericak-Vance; Teepu Siddique
Journal:  Nature       Date:  2011-08-21       Impact factor: 49.962

View more
  11 in total

1.  Better understanding the neurobiology of primary lateral sclerosis.

Authors:  P Hande Ozdinler; Mukesh Gautam; Oge Gozutok; Csaba Konrad; Giovanni Manfredi; Estela Area Gomez; Hiroshi Mitsumoto; Marcella L Erb; Zheng Tian; Georg Haase
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-11       Impact factor: 4.092

Review 2.  The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.

Authors:  Margrethe A Olesen; Francisca Villavicencio-Tejo; Rodrigo A Quintanilla
Journal:  Transl Neurodegener       Date:  2022-07-04       Impact factor: 9.883

3.  Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy.

Authors:  Albert Lee; Stephanie L Rayner; Serene S L Gwee; Alana De Luca; Hamideh Shahheydari; Vinod Sundaramoorthy; Audrey Ragagnin; Marco Morsch; Rowan Radford; Jasmin Galper; Sarah Freckleton; Bingyang Shi; Adam K Walker; Emily K Don; Nicholas J Cole; Shu Yang; Kelly L Williams; Justin J Yerbury; Ian P Blair; Julie D Atkin; Mark P Molloy; Roger S Chung
Journal:  Cell Mol Life Sci       Date:  2017-08-29       Impact factor: 9.261

4.  SOD1A4V aggregation alters ubiquitin homeostasis in a cell model of ALS.

Authors:  Natalie E Farrawell; Isabella Lambert-Smith; Kristen Mitchell; Jessie McKenna; Luke McAlary; Prajwal Ciryam; Kara L Vine; Darren N Saunders; Justin J Yerbury
Journal:  J Cell Sci       Date:  2018-06-12       Impact factor: 5.285

5.  Unbiased Label-Free Quantitative Proteomics of Cells Expressing Amyotrophic Lateral Sclerosis (ALS) Mutations in CCNF Reveals Activation of the Apoptosis Pathway: A Workflow to Screen Pathogenic Gene Mutations.

Authors:  Flora Cheng; Alana De Luca; Alison L Hogan; Stephanie L Rayner; Jennilee M Davidson; Maxinne Watchon; Claire H Stevens; Sonia Sanz Muñoz; Lezanne Ooi; Justin J Yerbury; Emily K Don; Jennifer A Fifita; Maria D Villalva; Hannah Suddull; Tyler R Chapman; Thomas J Hedl; Adam K Walker; Shu Yang; Marco Morsch; Bingyang Shi; Ian P Blair; Angela S Laird; Roger S Chung; Albert Lee
Journal:  Front Mol Neurosci       Date:  2021-04-27       Impact factor: 5.639

6.  Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.

Authors:  Csaba Konrad; Hibiki Kawamata; Kirsten G Bredvik; Andrea J Arreguin; Steven A Cajamarca; Jonathan C Hupf; John M Ravits; Timothy M Miller; Nicholas J Maragakis; Chadwick M Hales; Jonathan D Glass; Steven Gross; Hiroshi Mitsumoto; Giovanni Manfredi
Journal:  Mol Neurodegener       Date:  2017-10-24       Impact factor: 14.195

7.  Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis.

Authors:  Jordan M Wilkins; Oleksandr Gakh; Parijat Kabiraj; Christina B McCarthy; W Oliver Tobin; Charles L Howe; Claudia F Lucchinetti
Journal:  Aging (Albany NY)       Date:  2020-07-08       Impact factor: 5.682

8.  Accelerated transsulfuration metabolically defines a discrete subclass of amyotrophic lateral sclerosis patients.

Authors:  Qiuying Chen; Csaba Konrad; Davinder Sandhu; Dipa Roychoudhury; Benjamin I Schwartz; Roger R Cheng; Kirsten Bredvik; Hibiki Kawamata; Elizabeth L Calder; Lorenz Studer; Steven M Fischer; Giovanni Manfredi; Steven S Gross
Journal:  Neurobiol Dis       Date:  2020-08-01       Impact factor: 5.996

9.  TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis.

Authors:  Débora Lanznaster; Jérôme Bourgeais; Clement Bruno; Rudolf C Hergesheimer; Rose-Anne Thepault; Patrick Vourc'h; Philippe Corcia; Christian R Andres; Olivier Herault; Hélène Blasco
Journal:  Cells       Date:  2019-12-26       Impact factor: 6.600

10.  TDP-43 Cytoplasmic Translocation in the Skin Fibroblasts of ALS Patients.

Authors:  Miguel A Rubio; Mireia Herrando-Grabulosa; Roser Velasco; Israel Blasco; Monica Povedano; Xavier Navarro
Journal:  Cells       Date:  2022-01-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.